Literature DB >> 29878507

Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection.

M-L Wang1, E-Q Chen1, C-M Tao2, H Tang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29878507     DOI： 10.1111/apt.14673

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  2 in total

1.  Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.

Authors:  Yang Wang; Yanna Liu; Hao Liao; Zhongping Deng; Dandan Bian; Yan Ren; Guangxin Yu; Yingying Jiang; Li Bai; Shuang Liu; Mei Liu; Li Zhou; Yu Chen; Xinyue Chen; Zhongping Duan; Fengmin Lu; Sujun Zheng
Journal:  Int J Med Sci       Date:  2022-05-09       Impact factor: 3.642

2.  Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues.

Authors:  Yang Wang; Hao Liao; Zhongping Deng; Yanna Liu; Dandan Bian; Yan Ren; Guangxin Yu; Yingying Jiang; Li Bai; Shuang Liu; Mei Liu; Li Zhou; Yu Chen; Zhongping Duan; Fengmin Lu; Sujun Zheng
Journal:  J Viral Hepat       Date:  2022-03-17       Impact factor: 3.517
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.